| Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
| 1 |
00000001 - Document - Document and Entity Information |
Network |
* |
* |
http://info@tizianalifesciences.com/role/DocumentAndEntityInformation |
| 2 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3 |
Document And Entity Information |
Abstract |
|
|
TLSA:DocumentAndEntityInformationAbstract |
| 4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
| 5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
| 6 |
Trading Symbol |
Concept (Text/String) |
For Period |
|
dei:TradingSymbol |
| 7 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
| 8 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
| 9 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
| 10 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
| 11 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
| 12 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
| 13 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
| 14 |
Entity Voluntary Filers |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
| 15 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
| 16 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
| 17 |
Entity Emerging Growth Company |
Concept (Yes/No) |
For Period |
|
dei:EntityEmergingGrowthCompany |
| 18 |
Entity Ex Transition Period |
Concept (Yes/No) |
For Period |
|
dei:EntityExTransitionPeriod |
| 19 |
Entity Shell Company |
Concept (Yes/No) |
For Period |
|
dei:EntityShellCompany |
| 20 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
| 21 |
00000002 - Statement - Consolidated Balance Sheets |
Network |
* |
* |
http://info@tizianalifesciences.com/role/BalanceSheets |
| 22 |
Implied Table |
Table |
* |
* |
implied:Table |
| 23 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
| 24 |
ASSETS |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 25 |
Current assets: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
| 26 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 27 |
Prepayments and other receivables |
Concept (Monetary) |
As Of |
Debit |
TLSA:PrepaymentsandOtherReceivablesCurrent |
| 28 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
| 29 |
Property and Equipment, net |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 30 |
Total non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
| 31 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 32 |
LIABILITIES AND SHAREHOLDERS' EQUITY |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
| 33 |
Liabilities: |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
| 34 |
Current liabilities: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
| 35 |
Accounts payable and accrued expenses |
Concept (Monetary) |
As Of |
Credit |
TLSA:AccountsPayableAndAccruedExpensesCurrent |
| 36 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
| 37 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 38 |
Shareholders' Equity: |
Abstract |
|
|
ifrs-full:EquityAbstract |
| 39 |
Called up share capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
| 40 |
Share premium |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:SharePremium |
| 41 |
Share based payment reserve - Options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfSharebasedPayments |
| 42 |
Share based payment reserve - warrants |
Concept (Monetary) |
As Of |
Credit |
TLSA:ShareBasedPaymentReserveWarrants |
| 43 |
Convertible loan note reserve |
Concept (Monetary) |
As Of |
Credit |
TLSA:ReserveofConvertibleLoanNote |
| 44 |
Merger relief reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MergerReserve |
| 45 |
Other reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
| 46 |
Translation reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfExchangeDifferencesOnTranslation |
| 47 |
Capital reduction reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CapitalRedemptionReserve |
| 48 |
Retained earnings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
| 49 |
Total shareholders' equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 50 |
Total liabilities and shareholders' equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
| 51 |
00000003 - Statement - Consolidated Statements of Operations and Comprehensive Loss |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfOperationsAndComprehensiveLoss |
| 52 |
Implied Table |
Table |
* |
* |
implied:Table |
| 53 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
| 54 |
Revenue |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 55 |
Cost of revenue |
Concept (Monetary) |
For Period |
Debit |
TLSA:CostOfRevenues |
| 56 |
Gross Profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 57 |
Operating expenses: |
Abstract |
|
|
TLSA:OperatingExpenseAbstract |
| 58 |
Research and Development |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 59 |
Operating Expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
| 60 |
Total operating expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OperatingExpense |
| 61 |
Loss from operations |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 62 |
Other income/(expense): |
Abstract |
|
|
TLSA:OtherIncomeExpenseAbstract |
| 63 |
Finance Income/(expense) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncomeCost |
| 64 |
Loss from operations before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 65 |
Income tax provision |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 66 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 67 |
Other Comprehensive loss: |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
| 68 |
Currency translation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation |
| 69 |
Comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 70 |
Basic and diluted loss per share attributable to common shareholders |
Concept (Share) |
For Period |
|
ifrs-full:BasicAndDilutedEarningsLossPerShare |
| 71 |
00000004 - Statement - Consolidated Statements of Shareholders' Equity |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfShareholdersEquity |
| 72 |
Statement Table [Table] |
Table |
* |
* |
TLSA:IfrsStatementTable |
| 73 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 74 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 75 |
Issued Capital |
Member |
|
|
ifrs-full:IssuedCapitalMember |
| 76 |
Share Premium |
Member |
|
|
ifrs-full:SharePremiumMember |
| 77 |
Share Based Payment Reserve (Options) |
Member |
|
|
ifrs-full:ReserveOfSharebasedPaymentsMember |
| 78 |
Share Based Payment Reserve (warrants) |
Member |
|
|
TLSA:SharesToBeIssuedReserveMember |
| 79 |
Convertible Loan Note Reserve |
Member |
|
|
TLSA:ConvertibleLoanNoteReserveMember |
| 80 |
Merger Reserve |
Member |
|
|
ifrs-full:MergerReserveMember |
| 81 |
Other Reserves |
Member |
|
|
ifrs-full:OtherReservesMember |
| 82 |
Retained Earnings |
Member |
|
|
ifrs-full:RetainedEarningsMember |
| 83 |
Capital Redemption Reserve |
Member |
|
|
ifrs-full:CapitalRedemptionReserveMember |
| 84 |
Translation Reserve |
Member |
|
|
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember |
| 85 |
Capital Reduction Reserve |
Member |
|
|
TLSA:CapitalReductionReserveMember |
| 86 |
Statement Line Items [Line Items] |
LineItems |
|
|
TLSA:IfrsStatementLineItems |
| 87 |
Beginning Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 88 |
Transactions with owners |
Abstract |
|
|
TLSA:TransactionsWithOwnersAbstract |
| 89 |
Issue of share capital |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
| 90 |
Share based payment (options) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
| 91 |
Share based payment (warrants) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity |
| 92 |
Convertible loan note - equity component |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfConvertibleInstruments |
| 93 |
Option forfeited in the year |
Concept (Monetary) |
For Period |
Credit |
TLSA:OptionForfeited |
| 94 |
Options cancelled in the year |
Concept (Monetary) |
For Period |
Credit |
TLSA:CancellationOfOptions |
| 95 |
Cancellation of deferred shares |
Concept (Monetary) |
For Period |
Credit |
TLSA:CancellationofDeferredShares |
| 96 |
Capital Reduction |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
| 97 |
Prior Year Adjustment |
Concept (Monetary) |
For Period |
Debit |
TLSA:PriorYearAdjustment |
| 98 |
Convertible loan note interest |
Concept (Monetary) |
For Period |
Credit |
TLSA:IncreaseDecreaseThroughConvertibleLoanNoteInterest |
| 99 |
Convertible Loan Note Conversion |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 100 |
Total transactions with owners |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners |
| 101 |
Comprehensive income |
Abstract |
|
|
ifrs-full:ComprehensiveIncomeAbstract |
| 102 |
Loss for the period |
Concept (Monetary) |
For Period |
Credit |
TLSA:ProfitLoss1 |
| 103 |
Translation |
Concept (Monetary) |
For Period |
Credit |
TLSA:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation1 |
| 104 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
TLSA:ComprehensiveIncome1 |
| 105 |
Ending Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 106 |
00000005 - Statement - Consolidated Statements of Cash Flows |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfCashFlows |
| 107 |
Implied Table |
Table |
* |
* |
implied:Table |
| 108 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
| 109 |
CASH FLOWS FROM OPERATING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
| 110 |
Loss from operations before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 111 |
Adjustments to reconcile net loss to net cash used in operating activities: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
| 112 |
Convertible loan interest accrued |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForInterestExpense |
| 113 |
Convertible loan interest paid as equity |
Concept (Monetary) |
For Period |
Credit |
TLSA:ConvertibleLoanInterestPaidClassifiedAsOperatingActivities |
| 114 |
Shares issued in lieu of fees |
Concept (Monetary) |
For Period |
Debit |
TLSA:SharesIssuedInLieuOfFees |
| 115 |
Share based payment - options |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 116 |
Cancellation of options |
Concept (Monetary) |
For Period |
Credit |
TLSA:AdjustmentsForCancellationofOptions |
| 117 |
Share based payment - warrants |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForSharebasedPaymentsWarrants |
| 118 |
Net (increase)/decrease in operating assets/other receivables |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForDecreaseIncreaseInoperatingAssetsOtherReceivables |
| 119 |
Net increase/(decrease) in operating liabilities /other liabilities |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForDecreaseIncreaseInoperatingLiabilitiesOtherLiabilities |
| 120 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDepreciationExpense |
| 121 |
Loss on foreign exchange |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForForeignExchangeLossesGains |
| 122 |
Lease adjustment |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsforLeaseAdjustment |
| 123 |
Cash inflow from taxation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities |
| 124 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
| 125 |
CASH FLOWS FROM INVESTING ACTIVITIES |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
| 126 |
PPE |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| 127 |
Acquisition of other investments |
Concept (Monetary) |
For Period |
Credit |
TLSA:PaymentsForAcquisitionofOtherInvestments |
| 128 |
Net cash used in investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
| 129 |
CASH FLOWS FROM FINANCING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
| 130 |
Proceeds from issuance of ordinary shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
| 131 |
Proceeds from issuance of convertible loan notes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
| 132 |
Proceeds from issuance of warrants |
Concept (Monetary) |
For Period |
Debit |
TLSA:ProceedsFromIssuanceOfWarrant |
| 133 |
Fundraising cost |
Concept (Monetary) |
For Period |
Debit |
TLSA:FundraisingCost |
| 134 |
Net cash provided by financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
| 135 |
Net increase/(decrease) in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges |
| 136 |
Cash and cash equivalent, beginning of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 137 |
Exchange difference |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| 138 |
Cash and cash equivalent, end of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 139 |
00000006 - Disclosure - General Information |
Network |
* |
* |
http://info@tizianalifesciences.com/role/GeneralInformation |
| 140 |
Implied Table |
Table |
* |
* |
implied:Table |
| 141 |
General Information |
Abstract |
|
|
TLSA:GeneralInformationAbstract |
| 142 |
GENERAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfGeneralInformationAboutFinancialStatementsAndOrganization |
| 143 |
00000007 - Disclosure - Accounting Policies |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPolicies |
| 144 |
Implied Table |
Table |
* |
* |
implied:Table |
| 145 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
| 146 |
ACCOUNTING POLICIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
| 147 |
00000008 - Disclosure - Critical Accounting Estimates and Judgements |
Network |
* |
* |
http://info@tizianalifesciences.com/role/CriticalAccountingEstimatesAndJudgements |
| 148 |
Implied Table |
Table |
* |
* |
implied:Table |
| 149 |
Critical Accounting Estimates And Judgements |
Abstract |
|
|
TLSA:CriticalAccountingEstimatesandJudgementsAbstract |
| 150 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
| 151 |
00000009 - Disclosure - Operating Loss |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLoss |
| 152 |
Implied Table |
Table |
* |
* |
implied:Table |
| 153 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
| 154 |
OPERATING LOSS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory |
| 155 |
00000010 - Disclosure - Segmental Reporting |
Network |
* |
* |
http://info@tizianalifesciences.com/role/SegmentalReporting |
| 156 |
Implied Table |
Table |
* |
* |
implied:Table |
| 157 |
Segmental Reporting |
Abstract |
|
|
TLSA:SegmentalReportingAbstract |
| 158 |
SEGMENTAL REPORTING |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfSegmentReportingExplanatory |
| 159 |
00000011 - Disclosure - Employees |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Employees |
| 160 |
Implied Table |
Table |
* |
* |
implied:Table |
| 161 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
| 162 |
EMPLOYEES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory |
| 163 |
00000012 - Disclosure - Remuneration of Key Management Personnel |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnel |
| 164 |
Implied Table |
Table |
* |
* |
implied:Table |
| 165 |
Remuneration Of Key Management Personnel |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelAbstract |
| 166 |
REMUNERATION OF KEY MANAGEMENT PERSONNEL |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfRemunerationOfKeyManagementPersonnelTextBlock |
| 167 |
00000013 - Disclosure - Finance Costs |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCosts |
| 168 |
Implied Table |
Table |
* |
* |
implied:Table |
| 169 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
| 170 |
FINANCE COSTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceCostExplanatory |
| 171 |
00000014 - Disclosure - Taxation |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Taxation |
| 172 |
Implied Table |
Table |
* |
* |
implied:Table |
| 173 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
| 174 |
TAXATION |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
| 175 |
00000015 - Disclosure - Loss Per Share |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShare |
| 176 |
Implied Table |
Table |
* |
* |
implied:Table |
| 177 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
| 178 |
LOSS PER SHARE |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
| 179 |
00000016 - Disclosure - Property, IT and Equipment |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipment |
| 180 |
Implied Table |
Table |
* |
* |
implied:Table |
| 181 |
Property It And Equipment |
Abstract |
|
|
TLSA:PropertyItAndEquipmentAbstract |
| 182 |
PROPERTY, IT AND EQUIPMENT |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
| 183 |
00000017 - Disclosure - Other Receivables |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivables |
| 184 |
Implied Table |
Table |
* |
* |
implied:Table |
| 185 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
| 186 |
OTHER RECEIVABLES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
| 187 |
00000018 - Disclosure - Other Assets |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherAssets |
| 188 |
Implied Table |
Table |
* |
* |
implied:Table |
| 189 |
Other Assets |
Abstract |
|
|
TLSA:OtherAssetsAbstract |
| 190 |
OTHER ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherAssetsExplanatory |
| 191 |
00000019 - Disclosure - Investments in Subsidiaries |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiaries |
| 192 |
Implied Table |
Table |
* |
* |
implied:Table |
| 193 |
Disclosure of subsidiaries [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
| 194 |
INVESTMENTS IN SUBSIDIARIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory |
| 195 |
00000020 - Disclosure - Share Capital |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareCapital |
| 196 |
Implied Table |
Table |
* |
* |
implied:Table |
| 197 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 198 |
SHARE CAPITAL |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
| 199 |
00000021 - Disclosure - Share Based Payments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPayments |
| 200 |
Implied Table |
Table |
* |
* |
implied:Table |
| 201 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
| 202 |
SHARE BASED PAYMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
| 203 |
00000022 - Disclosure - Convertible Loan Notes |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotes |
| 204 |
Implied Table |
Table |
* |
* |
implied:Table |
| 205 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
| 206 |
CONVERTIBLE LOAN NOTES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
| 207 |
00000023 - Disclosure - Reserves |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Reserves |
| 208 |
Implied Table |
Table |
* |
* |
implied:Table |
| 209 |
Notes to Financial Statements |
Abstract |
|
|
TLSA:NotesToFinancialStatementsAbstract |
| 210 |
RESERVES |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfReservesExplanatoryTextBlock |
| 211 |
00000024 - Disclosure - Financial Instruments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialInstruments |
| 212 |
Implied Table |
Table |
* |
* |
implied:Table |
| 213 |
Financial Instruments |
Abstract |
|
|
TLSA:FinancialInstrumentsAbstract |
| 214 |
FINANCIAL INSTRUMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
| 215 |
00000025 - Disclosure - Capital Risk Management |
Network |
* |
* |
http://info@tizianalifesciences.com/role/CapitalRiskManagement |
| 216 |
Implied Table |
Table |
* |
* |
implied:Table |
| 217 |
Capital Risk Management |
Abstract |
|
|
TLSA:CapitalRiskManagementAbstract |
| 218 |
CAPITAL RISK MANAGEMENT |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialRiskManagementExplanatory |
| 219 |
00000026 - Disclosure - Trade and Other Payables |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayables |
| 220 |
Implied Table |
Table |
* |
* |
implied:Table |
| 221 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
| 222 |
TRADE AND OTHER PAYABLES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
| 223 |
00000027 - Disclosure - Related Party Transactions |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RelatedPartyTransactions |
| 224 |
Implied Table |
Table |
* |
* |
implied:Table |
| 225 |
Related party transactions [abstract] |
Abstract |
|
|
ifrs-full:RelatedPartyTransactionsAbstract |
| 226 |
RELATED PARTY TRANSACTIONS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
| 227 |
00000028 - Disclosure - Operating Leases |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeases |
| 228 |
Implied Table |
Table |
* |
* |
implied:Table |
| 229 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
| 230 |
OPERATING LEASES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfLeasesExplanatory |
| 231 |
00000029 - Disclosure - Post Balance Sheet Events - Post 31 December 2018 |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PostBalanceSheetEvents-Post31December2018 |
| 232 |
Implied Table |
Table |
* |
* |
implied:Table |
| 233 |
Post Balance Sheet Events - Post 31 December 2018 |
Abstract |
|
|
TLSA:PostBalanceSheetEventsAbstract |
| 234 |
POST BALANCE SHEET EVENTS - POST 31 DECEMBER 2018 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
| 235 |
00000030 - Disclosure - Financial Commitments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialCommitments |
| 236 |
Implied Table |
Table |
* |
* |
implied:Table |
| 237 |
Financial Commitments |
Abstract |
|
|
TLSA:FinancialCommitmentsAbstract |
| 238 |
FINANCIAL COMMITMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
| 239 |
00000031 - Disclosure - Accounting Policies (Policies) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesPolicies |
| 240 |
Implied Table |
Table |
* |
* |
implied:Table |
| 241 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
| 242 |
Basis of preparation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForBasisofPreparation |
| 243 |
Going Concern |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForGoingConcern |
| 244 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForBasisofConsolidation |
| 245 |
Business combination |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory |
| 246 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
| 247 |
Taxation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory |
| 248 |
Foreign currency translation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
| 249 |
License fees |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForLicenseFees |
| 250 |
Research and development |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory |
| 251 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
| 252 |
Share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
| 253 |
Property, IT and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
| 254 |
Impairment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory |
| 255 |
Operating leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
| 256 |
Share based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
| 257 |
Convertible loan notes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory |
| 258 |
00000032 - Disclosure - Accounting Policies (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesTables |
| 259 |
Implied Table |
Table |
* |
* |
implied:Table |
| 260 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
| 261 |
Schedule of the revisions |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutRevisions |
| 262 |
Schedule of estimated useful lives for the current period and the comparative period |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutEstimatedUsefulLives |
| 263 |
00000033 - Disclosure - Operating Loss (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLossTables |
| 264 |
Implied Table |
Table |
* |
* |
implied:Table |
| 265 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
| 266 |
Schedule of operating loss |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOperatingLoss |
| 267 |
00000034 - Disclosure - Employees (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/EmployeesTables |
| 268 |
Implied Table |
Table |
* |
* |
implied:Table |
| 269 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
| 270 |
Schedule of employees |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutEmployeesExplanatory |
| 271 |
00000035 - Disclosure - Remuneration of Key Management Personnel (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelTables |
| 272 |
Implied Table |
Table |
* |
* |
implied:Table |
| 273 |
Remuneration Of Key Management Personnel |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelAbstract |
| 274 |
Schedule of remuneration of key management personnel |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutRemunerationOfKeyManagementPersonnelTextBlock |
| 275 |
Schedule of share options were granted to directors |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfShareOptionsWereGrantedToDirectorsTextBlock |
| 276 |
00000036 - Disclosure - Finance Costs (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCostsTables |
| 277 |
Implied Table |
Table |
* |
* |
implied:Table |
| 278 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
| 279 |
Schedule of finance costs |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureDetailedInformationAboutOfFinanceCostTableTextBlock |
| 280 |
00000037 - Disclosure - Taxation (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TaxationTables |
| 281 |
Implied Table |
Table |
* |
* |
implied:Table |
| 282 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
| 283 |
Schedule of taxation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitTableTextBlock |
| 284 |
00000038 - Disclosure - Loss Per Share (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShareTables |
| 285 |
Implied Table |
Table |
* |
* |
implied:Table |
| 286 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
| 287 |
Schedule of basic loss per share |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOfEarningsPerShareTableTextBlock |
| 288 |
00000039 - Disclosure - Property, IT and Equipment (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipmentTables |
| 289 |
Implied Table |
Table |
* |
* |
implied:Table |
| 290 |
Property It And Equipment |
Abstract |
|
|
TLSA:PropertyItAndEquipmentAbstract |
| 291 |
Schedule of property, IT and equipment |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutPropertyItAndEquipmentTableTextBlock |
| 292 |
00000040 - Disclosure - Other Receivables (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivablesTables |
| 293 |
Implied Table |
Table |
* |
* |
implied:Table |
| 294 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
| 295 |
Schedule of other receivables |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOtherReceivablesTableTextBlock |
| 296 |
00000041 - Disclosure - Investments in Subsidiaries (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiariesTables |
| 297 |
Implied Table |
Table |
* |
* |
implied:Table |
| 298 |
Disclosure of subsidiaries [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
| 299 |
Schedule of interest in subsidiary undertakings |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureofDetailedInformationAboutSignificantInvestmentsInSubsidiariesExplanatory |
| 300 |
00000042 - Disclosure - Share Capital (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareCapitalTables |
| 301 |
Implied Table |
Table |
* |
* |
implied:Table |
| 302 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 303 |
Schedule of share capital |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareCapitalExplanatory |
| 304 |
00000043 - Disclosure - Share Based Payments (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsTables |
| 305 |
Implied Table |
Table |
* |
* |
implied:Table |
| 306 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
| 307 |
Schedule of share-based payment arrangements |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareBasedPaymentArrangements |
| 308 |
Schedule of share options outstanding |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareOptionsOutstanding |
| 309 |
Schedule of estimated a forfeiture rate of zero |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutforfeitureRate |
| 310 |
00000044 - Disclosure - Convertible Loan Notes (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesTables |
| 311 |
Implied Table |
Table |
* |
* |
implied:Table |
| 312 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
| 313 |
Schedule of planwise convertible loan note |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory |
| 314 |
00000045 - Disclosure - Financial Instruments (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialInstrumentsTables |
| 315 |
Implied Table |
Table |
* |
* |
implied:Table |
| 316 |
Financial Instruments |
Abstract |
|
|
TLSA:FinancialInstrumentsAbstract |
| 317 |
Schedule of financial liabilities based on contractual undiscounted payments |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfFinancialLiabilitiesBasedOnContractualUndiscountedPaymentsTableTextBlock |
| 318 |
00000046 - Disclosure - Trade and Other Payables (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayablesTables |
| 319 |
Implied Table |
Table |
* |
* |
implied:Table |
| 320 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
| 321 |
Schedule of trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfTradeAndOtherPayablesTableTextBlock |
| 322 |
00000047 - Disclosure - Operating Leases (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesTables |
| 323 |
Implied Table |
Table |
* |
* |
implied:Table |
| 324 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
| 325 |
Schedule of future minimum rentals payable under non-cancellable operating leases |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfFutureMinimumRentalsPayableUnderNoncancellableOperatingLeases |
| 326 |
00000048 - Disclosure - Accounting Policies (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesDetails |
| 327 |
IfrsDisclosureOfAccountingPoliciesTable [Table] |
Table |
* |
* |
TLSA:IfrsDisclosureOfAccountingPoliciesTable |
| 328 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 329 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 330 |
IT and equipment [Member] |
Member |
|
|
ifrs-full:CommunicationAndNetworkEquipmentMember |
| 331 |
Fixtures and fittings [Member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
| 332 |
IfrsDisclosureOfAccountingPoliciesLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsDisclosureOfAccountingPoliciesLineItems |
| 333 |
Estimated useful lives |
Concept (xbrli:durationItemType) |
For Period |
|
TLSA:EstimatedUsefulLives |
| 334 |
00000049 - Disclosure - Accounting Policies (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesDetailsTextual |
| 335 |
Implied Table |
Table |
* |
* |
implied:Table |
| 336 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
| 337 |
Percentage of shareholders |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
| 338 |
Issue of ordinary share capital |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 339 |
00000050 - Disclosure - Operating Loss (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLossDetails |
| 340 |
Implied Table |
Table |
* |
* |
implied:Table |
| 341 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
| 342 |
License fee |
Concept (Monetary) |
For Period |
Debit |
TLSA:Licensefee |
| 343 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationExpense |
| 344 |
Foreign exchange (gain)/losses |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss |
| 345 |
Operating Loss |
Concept (Monetary) |
For Period |
Debit |
TLSA:OperatingLoss |
| 346 |
00000051 - Disclosure - Employees (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/EmployeesDetails |
| 347 |
Implied Table |
Table |
* |
* |
implied:Table |
| 348 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
| 349 |
Staff costs comprised: |
Abstract |
|
|
TLSA:StaffCostsAbstract |
| 350 |
Directors' salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DirectorsRemunerationExpense |
| 351 |
Wages and salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:WagesAndSalaries |
| 352 |
Social security costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SocialSecurityContributions |
| 353 |
Share based payment charge |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
| 354 |
Employees, total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
| 355 |
The average monthly number of employees, including directors, employed by the group during the year was: |
Abstract |
|
|
ifrs-full:NumberAndAverageNumberOfEmployeesAbstract |
| 356 |
Research and Development |
Concept (Monetary) |
For Period |
Debit |
TLSA:ResearchAndDevelopment |
| 357 |
Corporate and administration |
Concept (Monetary) |
For Period |
Debit |
TLSA:CorporateAndAdministration |
| 358 |
Average monthly number of employees, including directors, employed by the group |
Concept (Monetary) |
For Period |
Debit |
TLSA:AverageMonthlyNumberOfEmployeesIncludingDirectorsEmployedByGroup |
| 359 |
00000052 - Disclosure - Remuneration of Key Management Personnel (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetails |
| 360 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
| 361 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 362 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 363 |
W Simon [Member] |
Member |
|
|
TLSA:WSimonMember |
| 364 |
G. Cerrone [Member] |
Member |
|
|
TLSA:GCerroneMember |
| 365 |
R. Dalla-Favera [Member] |
Member |
|
|
TLSA:RDallaFaveraMember |
| 366 |
K. Shailubhai [Member] |
Member |
|
|
TLSA:KShailubhaiMember |
| 367 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
| 368 |
Schedule of remuneration of key management personnel [Abstract] |
Abstract |
|
|
TLSA:ScheduleOfRemunerationOfKeyManagementPersonnelAbstract |
| 369 |
Directors fees |
Concept (Monetary) |
For Period |
Debit |
TLSA:DirectorsFees |
| 370 |
Salary |
Concept (Monetary) |
For Period |
Debit |
TLSA:Salary |
| 371 |
00000053 - Disclosure - Remuneration of Key Management Personnel (Details 1) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetails1 |
| 372 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
| 373 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 374 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 375 |
G. Cerrone [Member] |
Member |
|
|
TLSA:GCerroneMember |
| 376 |
K. Shailubhai [Member] |
Member |
|
|
TLSA:KShailubhaiMember |
| 377 |
L. Zanbeletti [Member] |
Member |
|
|
TLSA:ZanbelettiMember |
| 378 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
| 379 |
Schedule of share options were granted to directors [Abstract] |
Abstract |
|
|
TLSA:ScheduleOfShareOptionsWereGrantedToDirectorsAbstract |
| 380 |
Number of share options |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsWereGrantedToDirectors |
| 381 |
00000054 - Disclosure - Remuneration of Key Management Personnel (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetailsTextual |
| 382 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
| 383 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 384 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 385 |
Directors or Employees [Member] |
Member |
|
|
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember |
| 386 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
| 387 |
Remuneration of Key Management Personnel (Textual) |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelTextualAbstract |
| 388 |
Payments to a defined contribution pension schemes on behalf of directors or employees |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans |
| 389 |
00000055 - Disclosure - Finance Costs (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCostsDetails |
| 390 |
Implied Table |
Table |
* |
* |
implied:Table |
| 391 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
| 392 |
Group |
Abstract |
|
|
TLSA:GroupAbstract |
| 393 |
Finance charge accrued on convertible loan notes (recognized as debt) |
Concept (Monetary) |
For Period |
Debit |
TLSA:FinanceChargeAccruedOnConvertibleLoanNotes |
| 394 |
Total finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 395 |
00000056 - Disclosure - Taxation (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TaxationDetails |
| 396 |
Implied Table |
Table |
* |
* |
implied:Table |
| 397 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
| 398 |
Group |
Abstract |
|
|
TLSA:GroupAbstract |
| 399 |
Current year tax (credit) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CurrentTaxExpenseIncome |
| 400 |
Adjustments due to prior periods |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsDueToPriorPeriods |
| 401 |
Total tax (credit) for the period |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 402 |
The tax charge for the year is different from the standard rate of corporation tax in the United Kingdom of 21.49%. The difference can be reconciled as follows: |
Abstract |
|
|
TLSA:TaxChargeForYearIsDifferentFromStandardRateOfCorporationTaxAbstract |
| 403 |
Loss before taxation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 404 |
Loss charged at standard rate of corporation tax 19 % (2017: 19.25%; 2016: 20%) |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationLossChargedAtStandardRateOfCorporationTax |
| 405 |
Other timing differences |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationOtherTimingDifferences |
| 406 |
Expenses not deductible for taxation |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationExpensesNotDeductibleForTaxation |
| 407 |
Adjustments due to prior periods |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod |
| 408 |
Research and development claim |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationResearchAndDevelopmentClaim |
| 409 |
Other timing differences |
Concept (Monetary) |
For Period |
Credit |
TLSA:IncomeTaxReconciliationTaxesOtherTimingDifferences |
| 410 |
Income tax expense (benefit) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 411 |
00000058 - Disclosure - Loss Per Share (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShareDetails |
| 412 |
Implied Table |
Table |
* |
* |
implied:Table |
| 413 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
| 414 |
(Loss) attributable to equity holders of the company ($000) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity |
| 415 |
Weighted average number of ordinary shares in issue |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 416 |
Basic loss per share (cents per share) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
| 417 |
00000059 - Disclosure - Property, IT and Equipment (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipmentDetails |
| 418 |
IfrsPropertyItAndEquipmentTable [Table] |
Table |
* |
* |
TLSA:IfrsPropertyItAndEquipmentTable |
| 419 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 420 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 421 |
Fixtures and fittings [Member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
| 422 |
IT equipment [Member] |
Member |
|
|
ifrs-full:ComputerEquipmentMember |
| 423 |
IfrsPropertyItAndEquipmentLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsPropertyItAndEquipmentLineItems |
| 424 |
Cost |
Abstract |
|
|
TLSA:PropertyPlantEquipmentCostAbstract |
| 425 |
Beginning |
Concept (Monetary) |
As Of |
Debit |
TLSA:PropertyPlantEquipmentCost |
| 426 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
| 427 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsPropertyPlantAndEquipment |
| 428 |
Ending |
Concept (Monetary) |
As Of |
Debit |
TLSA:PropertyPlantEquipmentCost |
| 429 |
Depreciation |
Abstract |
|
|
TLSA:PropertyPlantEquipmentDepreciationAbstract |
| 430 |
Beginning |
Concept (Monetary) |
As Of |
Credit |
TLSA:DepreciationImpairmentPropertyPlantEquipment |
| 431 |
Charge in year |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
| 432 |
Ending |
Concept (Monetary) |
As Of |
Credit |
TLSA:DepreciationImpairmentPropertyPlantEquipment |
| 433 |
Net Book Value |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 434 |
00000060 - Disclosure - Other Receivables (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivablesDetails |
| 435 |
Implied Table |
Table |
* |
* |
implied:Table |
| 436 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
| 437 |
Group |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
| 438 |
Other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherReceivables |
| 439 |
Taxation receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax |
| 440 |
Related party receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:AmountsReceivableRelatedPartyTransactions |
| 441 |
Prepayments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Prepayments |
| 442 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 443 |
Total |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherReceivables |
| 444 |
00000062 - Disclosure - Investments in Subsidiaries (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiariesDetails |
| 445 |
IfrsDisclosureOfSignificantInvestmentsInSubsidiariesTable [Table] |
Table |
* |
* |
TLSA:IfrsDisclosureOfSignificantInvestmentsInSubsidiariesTable |
| 446 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 447 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 448 |
Tiziana Pharma Limited [Member] |
Member |
|
|
TLSA:TizianaPharmaLimitedMember |
| 449 |
Tiziana Therapeutics Inc [Member] |
Member |
|
|
TLSA:TizianaTherapeuticsIncMember |
| 450 |
Longevia Genomics SRL [Member] |
Member |
|
|
TLSA:LongeviaGenomicsSRLMember |
| 451 |
IfrsDisclosureOfSignificantInvestmentsInSubsidiariesLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsDisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
| 452 |
Name |
Concept (Text/String) |
For Period |
|
ifrs-full:NameOfSubsidiary |
| 453 |
Principal activity |
Concept (Text/String) |
For Period |
|
TLSA:PrincipalActivityInSubsidiaries |
| 454 |
Registered Address |
Concept (Text/String) |
For Period |
|
ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary |
| 455 |
Percentage shareholding |
Concept (Percent) |
For Period |
|
TLSA:PercentageofInvestmentsInSubsidiaries |
| 456 |
Country of incorporation |
Concept (Text/String) |
For Period |
|
ifrs-full:CountryOfIncorporation |
| 457 |
00000065 - Disclosure - Share Based Payments (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsDetails |
| 458 |
Implied Table |
Table |
* |
* |
implied:Table |
| 459 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
| 460 |
Weighted Average exercise price (cents) |
Abstract |
|
|
TLSA:WeightedAverageexercisepriceAbstract |
| 461 |
Outstanding at 1 January |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 462 |
Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 463 |
Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 464 |
Outstanding at 31 December |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 465 |
Exercisable at 31 December |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 466 |
Options ('000) |
Abstract |
|
|
TLSA:OptionsAbstract |
| 467 |
Outstanding at 1 January |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsOutstanding |
| 468 |
Granted |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsGranted |
| 469 |
Forfeited |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsForfeited |
| 470 |
Outstanding at 31 December |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsOutstanding |
| 471 |
Exercisable at 31 December |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsExercisable |
| 472 |
00000067 - Disclosure - Share Based Payments (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsDetailsTextual |
| 473 |
Implied Table |
Table |
* |
* |
implied:Table |
| 474 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
| 475 |
Share Based Payments (Textual) |
Abstract |
|
|
TLSA:ShareBasedPaymentsTextualAbstract |
| 476 |
Fair value of the share option instruments |
Concept (Monetary) |
As Of |
Credit |
TLSA:FairValueshareoptioninstruments |
| 477 |
Fair value of the warrant instruments |
Concept (Monetary) |
As Of |
Credit |
TLSA:Fairvalueofwarrantinstruments |
| 478 |
Share-based payment |
Concept (Monetary) |
For Period |
Debit |
TLSA:SharePasedPayment |
| 479 |
Expected term of the awards |
Concept (xbrli:durationItemType) |
For Period |
|
TLSA:ExpectedTermOfAwards |
| 480 |
00000068 - Disclosure - Convertible Loan Notes (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesDetails |
| 481 |
Implied Table |
Table |
* |
* |
implied:Table |
| 482 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
| 483 |
Convertible loan notes issued |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NotesAndDebenturesIssued |
| 484 |
Accrued interest |
Concept (Monetary) |
As Of |
Credit |
TLSA:Accruedinterest |
| 485 |
Planwise Convertible Loan Note |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 486 |
00000069 - Disclosure - Convertible Loan Notes (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesDetailsTextual |
| 487 |
Implied Table |
Table |
* |
* |
implied:Table |
| 488 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
| 489 |
Convertible Loan Notes (Textual) |
Abstract |
|
|
TLSA:ConvertibleLoanNotesTextualAbstract |
| 490 |
Description of convertible loan notes |
Concept (Text/String) |
For Period |
|
TLSA:DescriptionofBorrowings |
| 491 |
00000070 - Disclosure - Reserves (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ReservesDetails |
| 492 |
Implied Table |
Table |
* |
* |
implied:Table |
| 493 |
Notes to Financial Statements |
Abstract |
|
|
TLSA:NotesToFinancialStatementsAbstract |
| 494 |
Capital reduction reserve |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
| 495 |
00000072 - Disclosure - Trade and Other Payables (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayablesDetails |
| 496 |
Implied Table |
Table |
* |
* |
implied:Table |
| 497 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
| 498 |
Trade payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
| 499 |
Accruals |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
| 500 |
Convertible loan note liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentPayables |
| 501 |
Related party payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties |
| 502 |
Total |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
| 503 |
00000074 - Disclosure - Operating Leases (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesDetails |
| 504 |
OperatingLeasesTable [Table] |
Table |
* |
* |
TLSA:OperatingLeasesTable |
| 505 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 506 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 507 |
Less than one year [Member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 508 |
Between one and five years [Member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 509 |
OperatingLeasesLineItems [Line Items] |
LineItems |
|
|
TLSA:OperatingLeasesLineItems |
| 510 |
Future minimum rentals payable under non-cancellable operating leases |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumFinanceLeasePaymentsPayable |
| 511 |
00000075 - Disclosure - Operating Leases (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesDetailsTextual |
| 512 |
Implied Table |
Table |
* |
* |
implied:Table |
| 513 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
| 514 |
Operating Leases (Textual) |
Abstract |
|
|
TLSA:OperatingLeasesTextualAbstract |
| 515 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContingentRentsRecognisedAsExpenseClassifiedAsOperatingLease |